We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.6B
AUM Growth
-$325M
Cap. Flow
-$723M
Cap. Flow %
-4.97%
Top 10 Hldgs %
7.37%
Holding
1,080
New
68
Increased
314
Reduced
422
Closed
79

Top Sells

Rank Stock Value
1
IMXI icon
International Money Express
IMXI
+$42M
2
OLN icon
Olin
OLN
+$40.2M
3
BC icon
Brunswick
BC
+$36.7M
4
AA icon
Alcoa
AA
+$33.9M
5
USCR
U S Concrete, Inc.
USCR
+$31.9M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 20.04%
3 Financials 15.03%
4 Consumer Discretionary 13.3%
5 Healthcare 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLIC icon
1
Kulicke & Soffa
KLIC
$4.34B
$172M 1.18%
2,803,337
-361,042
-11% -$19.4M
MKSI icon
2
MKS Inc
MKSI
$17.4B
$139M 0.95%
779,393
-110,673
-12% -$20.1M
KW
3
DELISTED
Kennedy-Wilson Holdings
KW
$107M 0.73%
5,368,439
+16,392
+0.3% +$331K
KWR icon
4
Quaker Houghton
KWR
$2.58B
$106M 0.73%
446,637
-2,267
-0.5% -$542K
LNN icon
5
Lindsay Corp
LNN
$1.14B
$94.6M 0.65%
572,595
-34,510
-6% -$5.68M
VNT icon
6
Vontier
VNT
$4.54B
$93.1M 0.64%
2,856,466
+1,538,803
+117% +$50.7M
JBTM
7
JBT Marel
JBTM
$7.35B
$92.7M 0.64%
650,082
-63,597
-9% -$8.87M
MLAB icon
8
Mesa Laboratories
MLAB
$551M
$90.2M 0.62%
332,746
+30,705
+10% +$7.79M
LECO icon
9
Lincoln Electric
LECO
$14.1B
$89.6M 0.62%
680,601
-42,095
-6% -$5.39M
KAI icon
10
Kadant
KAI
$3.58B
$88.8M 0.61%
504,286
-21,149
-4% -$3.72M
ACA icon
11
Arcosa
ACA
$7.11B
$88M 0.6%
1,498,170
-130,910
-8% -$8.1M
FARO
12
DELISTED
Faro Technologies
FARO
$84.3M 0.58%
1,083,754
+28,245
+3% +$2.23M
VSH icon
13
Vishay Intertechnology
VSH
$4.6B
$84.3M 0.58%
3,736,243
+424,174
+13% +$10.2M
UPLD icon
14
Upland Software
UPLD
$13.3M
$84.2M 0.58%
204,438
+82,343
+67% +$36.2M
MORN icon
15
Morningstar
MORN
$7.55B
$83.8M 0.58%
325,869
-8,531
-3% -$2.07M
CCMP
16
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$83.2M 0.57%
551,746
+55,121
+11% +$9.13M
IOSP icon
17
Innospec
IOSP
$2.09B
$83M 0.57%
916,275
+1,370
+0.1% +$136K
ENOV icon
18
Enovis
ENOV
$1.74B
$82.2M 0.56%
1,042,323
-191,876
-16% -$14.7M
HUN icon
19
Huntsman Corp
HUN
$2.1B
$82.2M 0.56%
3,098,683
-751,053
-20% -$21.3M
SEIC icon
20
SEI Investments
SEIC
$12.3B
$81M 0.56%
1,307,855
+47,517
+4% +$2.96M
RL icon
21
Ralph Lauren
RL
$22.4B
$79.6M 0.55%
675,857
-75,664
-10% -$9.47M
VMI icon
22
Valmont Industries
VMI
$8.86B
$78.5M 0.54%
332,640
-9,373
-3% -$2.27M
AL
23
DELISTED
Air Lease Corp
AL
$77.7M 0.53%
1,860,910
-66,538
-3% -$3.09M
ESI icon
24
Element Solutions
ESI
$8.48B
$74.6M 0.51%
3,192,450
+28,678
+0.9% +$631K
FORR icon
25
Forrester Research
FORR
$199M
$71.2M 0.49%
1,555,465
+41,866
+3% +$1.81M

Similar funds

Royce & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Royce & Associates held 1,080 positions worth $14.6B, down 2.2% from $14.9B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Royce & Associates withdrew a net $723M in Q2 2021, closing 79 positions and reducing 422 holdings. Its most notable exit was Olin, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Organon & Co worth $16.5M.

  • Royce & Associates's largest Q2 2021 buy was Organon & Co: 546,803 shares worth $16.5M.
  • Royce & Associates added most to Vontier in Q2 2021, an estimated $50.7M increase.
  • Royce & Associates's biggest Q2 2021 reduction was International Money Express, cutting an estimated $42M.
  • Royce & Associates fully exited Olin in Q2 2021, selling an estimated $40.2M.
  • Royce & Associates's ten largest holdings make up 7.4% of its $14.6B portfolio in Q2 2021.
  • Royce & Associates opened 68 new positions and closed 79 in Q2 2021.
  • Royce & Associates's portfolio value fell 2.2% quarter-over-quarter to $14.6B.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.